Results 21 to 30 of about 21,916 (184)

SAVOR-TIMI to DECLARE-TIMI: A review on cardiovascular outcome trials of incretin-modulators and gliflozins

open access: yesIndian Journal of Endocrinology and Metabolism, 2019
Since 2008 United State (US) food drug administration mandate, several newer anti-diabetic drugs (ADD) have undergone a mandatory cardiovascular (CV) outcome trial (CVOT) in type diabetes (T2DM) patients with high CV risk. These includes CVOT done with dipeptidyl-peptidase-4 inhibitors, sodium-glucose co-transporter-2 inhibitors and glucagon-like ...
Awadhesh K Singh, Ritu Singh
openaire   +3 more sources

Unlocking Object Detection in Vision-Language Models

open access: yesIEEE Access
Vision-Language Models (VLMs) trained on large-scale multimodal data develop latent object detection capabilities through grounding pretraining, yet these remain largely untapped for general-purpose detection.
Andrei-Stefan Bulzan   +2 more
doaj   +1 more source

Concomitant Use of Single Antiplatelet Therapy With Edoxaban or Warfarin in Patients With Atrial Fibrillation: Analysis From the ENGAGE AF‐TIMI48 Trial

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundWe studied the concomitant use of single antiplatelet therapy (SAPT) on the efficacy and safety of the anti‐Xa agent edoxaban in patients with atrial fibrillation (AF). Methods and ResultsENGAGE AF‐TIMI 48 was a randomized trial that compared 2
Haiyan Xu   +9 more
doaj   +1 more source

RT-LiDAR: Time-Bounded Real-Time LiDAR Driver for Critical IoT Applications

open access: yesIEEE Access
In Internet of Things networks, sensing represents the primary function of the Edge Layer while in Real-Time critical systems the whole functionality of this layer needs to be strictly time-bounded.
Valentin Stangaciu   +2 more
doaj   +1 more source

Cystatin C for Risk Stratification in Patients After an Acute Coronary Syndrome

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2018
Background Cystatin C (Cys‐C) is a marker of renal function that has shown prognostic value for cardiovascular risk stratification across different patient populations.
Simon Correa   +7 more
doaj   +1 more source

Digoxin Use and Subsequent Clinical Outcomes in Patients With Atrial Fibrillation With or Without Heart Failure in the ENGAGE AF‐TIMI 48 Trial

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2017
BackgroundDigoxin is widely used in patients with atrial fibrillation despite the lack of randomized controlled trials. Observational studies report conflicting results regarding its association with mortality, perhaps because of residual confounding by ...
Alon Eisen   +11 more
doaj   +1 more source

Heavy and Lightweight Deep Learning Models for Semantic Segmentation: A Survey

open access: yesIEEE Access
Semantic segmentation is an important computer vision task due to its numerous real-world applications such as autonomous driving, video surveillance, medical image analysis, robotics, augmented reality, among others, and its popularity increased with ...
Cristina Carunta   +2 more
doaj   +1 more source

Plasma Omega‐3 Fatty Acids and the Risk of Cardiovascular Events in Patients After an Acute Coronary Syndrome in MERLIN‐TIMI 36

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background Plasma omega‐3 polyunsaturated fatty acids (ω3‐PUFAs) have been shown to be inversely correlated with the risk of cardiovascular death in primary prevention.
Thomas A. Zelniker   +7 more
doaj   +1 more source

Efficacy and Safety of Edoxaban in Elderly Patients With Atrial Fibrillation in the ENGAGE AF–TIMI 48 Trial

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2016
BackgroundElderly patients with atrial fibrillation are at higher risk of both ischemic and bleeding events compared to younger patients. In a prespecified analysis from the ENGAGE AF‐TIMI 48 trial, we evaluate clinical outcomes with edoxaban versus ...
Eri Toda Kato   +13 more
doaj   +1 more source

Influence of the Residual Gensini Score on Prognosis of Patients With ST‐Elevation Myocardial Infarction

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The residual Gensini score (rGS) was developed to quantify the severity of coronary atheroma burden after coronary revascularisation. The predictive value of the rGS for clinical outcomes in patients with ST‐segment elevation myocardial infarction (STEMI) remains unexplored.
Batric Popovic   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy